Ellington Financial Inc. Free cash flow increased by 92.0% to -$10.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 92.0%, from -$126.40M to -$10.13M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $33.58M | $14.35M | $32.93M | $48.33M | -$48.69M | -$43.35M | -$70.90M | -$78.95M | -$59.46M | -$88.60M | -$141.69M | -$140.78M | -$126.40M | -$10.13M |
| QoQ Change | — | -57.3% | +129.5% | +46.8% | -200.7% | +11.0% | -63.6% | -11.4% | +24.7% | -49.0% | -59.9% | +0.6% | +10.2% | +92.0% |
| YoY Change | — | — | — | +43.9% | -247.8% | -189.7% | — | — | -22.1% | -104.4% | -99.8% | -78.3% | -112.6% | +92.0% |